Sage Therapeutics Inc (SAGE) — Free Cash Flow Generation Index

Latest as of December 2020: 1.00x

Sage Therapeutics Inc (SAGE) has a Free Cash Flow Generation Index of 1.00x as of December 2020. Free cash flow of $1.01 Billion represents 1% of operating cash flow ($1.01 Billion). Explore Sage Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$1.01 Billion
USD

Operating Cash Flow

$1.01 Billion
USD

Capital Expenditures

$1.00K
USD

Sage Therapeutics Inc Free Cash Flow Generation Index (2020–2020)

Historical FCF Generation Index trend for Sage Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Sage Therapeutics Inc generate cash.

Annual Free Cash Flow Generation for Sage Therapeutics Inc (2020–2020)

Year-by-year Free Cash Flow Generation Index for Sage Therapeutics Inc. Check cash flow reinvestment rate of Sage Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2020 1.00x $663.93 Million $664.28 Million $345.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).